The developments in enteral feeding for Crohn's disease in the past decade are critically reviewed. The advent of amino acid based chemically defined elemental diets signalled the end of 'total bowel rest' in the management of these patients.
Subsequently, controlled clinical trials showed that elemental diets were as effective as corticosteroids in The possibility that the already damaged mucosa will be traumatised and therefore further damaged by food was the main reason for using 'total bowel rest' in the management of acute attacks of Crohn's disease.4 'Total bowel rest' was, however, achieved at the cost of protein energy malnutrition if standard IV glucose was the sole source of calories given. The use of total parenteral nutrition satisfied the need for 'bowel rest' while permitting the patient to achieve a satisfactory nutritional state.5-8 Moreover, the subsequent belief that intraluminal dietary antigens could play a major part in the pathophysiology of inflammation in Crohn's disease was an additional reason for prescribing 'total bowel rest' in patient management.8 10 It has to be emphasised that in most series parenteral nutrition was added to corticosteroid therapy, thus making the case for total parenteral nutrition as primary therapy in Crohn's disease confusing. 1 ' There is, however, as far as we are aware no controlled data to support the use of total parenteral nutrition as a unique primary treatment for active Crohn's disease.
In the belief that some food products could exert an adverse effect on the intestine of patients with Crohn's disease, the use of exclusion diets were proposed both as primary treatment and in the prevention of acute attacks of the disease.'2 Definitive proof, however, concerning the relation between the reintroduction of conventional food ingestion and relapse of the disease has hitherto not been provided.
Use of 'elemental' diets in Crohn's disease In the past decade much interest has surrounded the use of predigested chemically defined elemental diets in the management of acute exacerbations of Crohn's disease. In the diets used in the early studies, nitrogen was provided in the form of free L-amino acids. ' for trials assessing the effects of enteral nutrition in Crohn's disease in which an increase in diarrhoea may either result as a consequence of worsening of the disease or as a consequence of side effect of the nutritional treatment. In such studies, the use of an index as the CDAI that is loaded towards the daily number of bowel movements would seem not to be the most advisable index to use.
In a number of previous studies,19 29 (Fig 1 and 2 ). In conclusion, there are sufficient data available to suggest that enteral nutrition has a primary therapeutic role in the management of acute exacerbations of Crohn's disease. Further work is needed to explore the possibility that the beneficial effects of enteral nutrition may not be related, as previously supposed, to the composition of the nitrogen source but the composition of the fat component of the enteral formulas so far subjected to clinical trial.
